Thermopylae Holdings Ltd.

CIK: 0001834449

Transaction Breakdown

Open Market Buys (P)3 (60.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (40.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ABCL

AbCellera Biologics Inc.

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (5 total)

ABCL
AbCellera Biologics Inc.
Feb 27, 2026
Purchase(P)
Direct
38K shares at avg. $3.44$131K
ABCL
AbCellera Biologics Inc.
Feb 26, 2026
Purchase(P)
Direct
177.5K shares at avg. $3.27$580K
ABCL
AbCellera Biologics Inc.
Dec 18, 2025
Gift(G)
Direct
225K shares-
ABCL
AbCellera Biologics Inc.
Mar 11, 2025
Purchase(P)
Direct
343.6K shares at avg. $2.16$742K
ABCL
AbCellera Biologics Inc.
Dec 4, 2024
Gift(G)
Direct
286K shares-

		Type	Shares	Price		Ownership
Feb 27, 2026	ABCL AbCellera Biologics Inc.	Purchase(P)	38,000	$3.44	$130,720	Direct
Feb 26, 2026	ABCL AbCellera Biologics Inc.	Purchase(P)	177,457	$3.27	$580,284	Direct
Dec 18, 2025	ABCL AbCellera Biologics Inc.	Gift(G)	225,000	-	-	Direct
Mar 11, 2025	ABCL AbCellera Biologics Inc.	Purchase(P)	343,631	$2.16	$742,243	Direct
Dec 4, 2024	ABCL AbCellera Biologics Inc.	Gift(G)	286,000	-	$0	Direct

1-5 of 5 transactions

About Thermopylae Holdings Ltd.

Thermopylae Holdings Ltd. (SEC CIK 0001834449) files insider reports with the SEC as 10% Owner of AbCellera Biologics Inc. (ABCL).

Signal8 holds 5 ownership filings by Thermopylae Holdings Ltd., all Form 4s, filed between Dec 5, 2024 and Mar 2, 2026. Those filings report 5 transactions, from Dec 4, 2024 to Feb 27, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Thermopylae Holdings Ltd.'s filings is in VANCOUVER, A1.

Recent filings by Thermopylae Holdings Ltd.

Feb 27, 2026: Open-market purchase of ABCL shares (Form 4, code P).
Feb 26, 2026: Open-market purchase of ABCL shares (Form 4, code P).
Dec 18, 2025: Gift of ABCL shares (Form 4, code G).
Mar 11, 2025: Open-market purchase of ABCL shares (Form 4, code P).
Dec 4, 2024: Gift of ABCL shares (Form 4, code G).

Other insiders filing for AbCellera Biologics Inc. (ABCL)

Hayden Michael R, Director
Montalbano John S., Director
Booth Andrew, Chief Financial Officer
Seely Lynn, Director
Sandor Victor, Director
Quake Stephen, Director

How to read Form 4 transaction codes